Literature DB >> 21275122

The pathology of breast cancer in Jamaica: the National Public Health Laboratory study.

S E Shirley1, P A Sinclair, M A Stennett, G Codrington, R Bhatt, C T Escoffery.   

Abstract

OBJECTIVE: To document the pathologic features of breast cancer in Jamaica.
METHODS: The pathology reports and slides of all patients diagnosed with breast cancer at the National Public Health Laboratory between January 1999 and December 2002 were reviewed. Patient age and gender side involved, number of tumours identified, tumour size, histologic type, histologic grade, degree of lymph node involvement and parish of origin of the specimens were documented.
RESULTS: There were 772 patients, 762 females and 10 males; age range 21 to 96 (mean 57.9 +/- 15.9) years. There were 778 specimens (6 bilateral cases), the majority of whom originated from Kingston and St Andrew (34.7%). Manchester (22.9%), St Catherine (13.9%) and St Ann (7.3%) were the next most common sources. The left breast was involved in 50.5% of cases. Gross tumour was identified in 641 (82.4%) specimens, the number of tumours ranging from 1 - 6 (mean 1.1 +/- 0.6). The maximum gross tumour dimension ranged from 0.3 to 15 cm (mean 4.1 +/- 2.7 cm). Infiltrating duct carcinoma was the predominant histologic type (69.3 %); 13.3%, 49.5% and 37.2 % of all infiltrating tumours were well, moderately and poorly differentiated respectively. In-situ lesions (7.1% of tumours) were all of the ductal phenotype. Axillary lymph nodes were submitted in 296 (38.1%) cases; metastatic disease was identified in 224 (75.7%) of these. The total number of nodes submitted ranged from 1 - 34 (mean 10.8 +/- 6.7) with an average of 6.1 (+/- 5.8) being positive for metastases (range 1 - 29).
CONCLUSIONS: The pathologic features of breast cancer documented in this series including average tumour size, histologic types and grade and the degree of lymph node involvement are consistent with patient presentation at relatively advanced stages of disease and highlight the urgent need for public health intervention including a national screening programme.

Entities:  

Mesh:

Year:  2010        PMID: 21275122

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  6 in total

Review 1.  Social determinants of breast cancer in the Caribbean: a systematic review.

Authors:  Catherine R Brown; Ian R Hambleton; Shawn M Hercules; Miriam Alvarado; Nigel Unwin; Madhuvanti M Murphy; E Nigel Harris; Rainford Wilks; Marlene MacLeish; Louis Sullivan; Natasha Sobers-Grannum
Journal:  Int J Equity Health       Date:  2017-04-05

2.  Breast Cancer in Jamaica: Trends From 2010 to 2014-Is Mortality Increasing?

Authors:  Sonya Reid; Kayon Donaldson-Davis; Douladel Willie-Tyndale; Camelia Thompson; Gilian Wharfe; Tracey Gibson; Denise Eldemire-Shearer; Kenneth James
Journal:  JCO Glob Oncol       Date:  2020-06

3.  Breast cancer screening patterns in Jamaican women: review of the largest national mammography clinic.

Authors:  Sheray N Chin; Derria Cornwall; Derek I Mitchell; Michael E McFarlane; Joseph M Plummer
Journal:  BMC Womens Health       Date:  2021-04-23       Impact factor: 2.809

4.  Breast Cancer in Jamaica: Stage, Grade and Molecular Subtype Distributions Across Age Blocks, the Implications for Screening and Treatment.

Authors:  Jason Copeland; Abimbola Oyedeji; Neggoshane Powell; Cherian J Cherian; Yoshihisa Tokumaru; Vijayashree Murthy; Kazuaki Takabe; Jessica Young
Journal:  World J Oncol       Date:  2021-07-10

5.  Breast Cancer in the Bahamas in 2009-2011.

Authors:  K Mungrue; H Chase; J Gordon; D Knowles; K Lockhart; N Miller; T Morley; L Sealey; B Turner
Journal:  Breast Cancer (Auckl)       Date:  2016-04-21

6.  Breast Cancer Research in the Caribbean: Analysis of Reports From 1975 to 2017.

Authors:  Camille Ragin; Rishika Banydeen; Christine Zhang; Athena Ben; Victoria Calabrese; Nina N Villa; Jade Reville; Shaoni Dasgupta; Mausumi Bandyopadhyay; Delroy Louden; Subhajit Dasgupta
Journal:  J Glob Oncol       Date:  2018-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.